Canada Pension Plan Investment Board’s Aldeyra Therapeutics ALDX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Buy	94,300 +46,900	+99%	+$80.6K	﹤0.01%	1598
2026 Q1	$80.1K	Buy	47,400 +11,900	+34%	+$52.1K	﹤0.01%	1659
2025 Q4	$184K	Buy	+35,500	New	+$182K	﹤0.01%	1689
2019 Q2	–	Sell	-275	Closed	-$2K	–	1238
2019 Q1	$2K	Buy	+275	New	+$2.34K	﹤0.01%	1487

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Canada Pension Plan Investment Board's ALDX Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Aldeyra Therapeutics (ALDX) stake by 99% in Q2 2026, buying an estimated $80.6K and bringing the position to 94,300 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #1598.

Canada Pension Plan Investment Board first reported a position in ALDX in Q1 2019 and has held it in 4 quarters since. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

Canada Pension Plan Investment Board held 94,300 shares of Aldeyra Therapeutics worth $201K as of Q2 2026.
Canada Pension Plan Investment Board bought 46,900 Aldeyra Therapeutics shares in Q2 2026, an estimated $80.6K.
Aldeyra Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1598 holding.
Canada Pension Plan Investment Board first reported a position in Aldeyra Therapeutics in Q1 2019 and has held it in 4 quarters since.
107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.